International Conference on Nanotechnology at Bio-Medical Interfaces (NANOBIO2012) hosted by Amrita Centre for Nanosciences, Amrita Institute of Medical Sciences, Kochi was inaugurated by SWAMI PURNAMRITANANDA PURI, General Secretary, Mata Amritanandamayi Math Trustee, Amrita University on feb 21st, 2012.
SAMPOOJYA SWAMI PURNAMRITANANDA PURI , General Secretary , Mata Amritanandamayi Math Trustee, Amrita University, inaugurated the 3 day conference.
One of the highlights of the conference was a new product Nanophotomedicine, a soon-to-be-released medicine from bench to bedside for curing neuroendocrine tumors was officially launched at NANOBIO.The product was developed jointly by Amrita Centre for Nanosciences and Erasmus University, Rotterdam, Netherlands.
Dr. Nair explained that the Nanophotomedicine extremely efficiently removes the tumor in a much more efficient way with little toxicity. The product is able to cure neuroendocrine tumors including brain tumors.
The product was initially developed at ACNS by a team led by Dr. Manzoor Koyakkutty, Professor, ACNS. And the outcomes of this initial development lead to collaborative measures. The product was then subsequently developed further by animal studies at Erasmus University, Netherlands.The product was officially handed over to Dr. Ivo Timmermans, CEO of Nano4therapy by Dr. Manzoor Koyakkutty, Professor at ACNS.
Dr. Shantikumar V Nair, Director, Amrita Centre for Nanosciences welcomed delegates of the International Conference.
After the Conference Inauguration, the session started with a keynote address of Dr Antonios G. Mikos from Rice University, USA. His topic was entitled “Harnessing Nanotechnology in Approaches to promote the regeneration of the tissue”. In this, he explained about the recent advances in nanotechnology had provided powerful tools to regenerate the tissues.
Dr Neil P Desai, Vice President of Research & Development, Abraxis BioScience, Inc., USA delivered the Keynote address. His topic was entitled Nanomedicine –from Bench to the Clinic and Beyond. According to him, Nanotechnology was emerged and developed rapidly in Medicinal field so as to improve the delivery of a multitude of therapeutic moieties and to increase sensitivity, speed and specificity of diagnostics.
A Keynote address was delivered by Dr.Shantikumar Nair in which Nanotechnology played a vital role of a translational aspect going from the lab to the clinic.Dr Cato T Laurencin also delivered a keynote address on “Bioresorbable Nanostructures for Musculoskeletal Tissue Regeneration”.
Dr Avadesh Surolia, Director, National Institute of Immunology, New Delhi delivered the keynote address was entitled “Nanotized Insulin for a Sustained Treatment of Diabetes”. In this he explained about the future application of protein therapeutics, which will be the future drug for chronic diseases such as diabetes, multiple sclerosis.
Dr. Beth Pruit , Stanford University, USA and Dr Johnna S Temenoff, Emory University, USA made a plenary talk on “Microsystem Bioreactors and the Mechanobiology of in vitro Tissues” and “Hydrogel platforms to examine the role of Paracrine Signaling in MSC Differentiation”.